BridgeBio Oncology Therapeutics, Inc.
BBOT
$6.76
-$2.11-23.76%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 71.78% | 85.88% | 173.38% | -- | -- |
| Total Receivables | -38.63% | 265.00% | 376.54% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 272.58% | 427.38% | 119.72% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 70.27% | 88.57% | 172.47% | -- | -- |
|
|
|||||
| Total Current Assets | 70.27% | 88.57% | 172.47% | -- | -- |
| Net Property, Plant & Equipment | -13.54% | -6.04% | 570.61% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 136.84% | 120.84% | 148.12% | -- | -- |
| Total Assets | 149.06% | 178.74% | 172.90% | -- | -- |
|
|
|||||
| Total Accounts Payable | 206.24% | 230.96% | -55.30% | -- | -- |
| Total Accrued Expenses | 77.70% | 86.09% | 152.45% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 73.13% | 8,866.67% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 198.79% | -83.43% | -85.12% | -- | -- |
| Total Other Current Liabilities | 198.79% | -83.43% | -85.12% | -- | -- |
| Total Current Liabilities | 89.48% | 79.83% | 78.96% | -- | -- |
|
|
|||||
| Total Current Liabilities | 89.48% | 79.83% | 78.96% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -22.04% | -20.32% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 80.06% | 69.92% | 90.42% | -- | -- |
|
|
|||||
| Common Stock & APIC | 1,622.78% | 1,640.39% | 1,663.17% | -- | -- |
| Retained Earnings | -66.71% | -63.00% | -60.24% | -- | -- |
| Treasury Stock & Other | -1,980.39% | -613.61% | -95.40% | -- | -- |
| Total Common Equity | 241.88% | 286.11% | 330.13% | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 241.88% | 286.11% | 330.13% | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 165.96% | 202.33% | 184.06% | -- | -- |
|
|
|||||